Exosomes as biomarkers and therapeutic measures for ischemic stroke

被引：0

作者：

Shi, Yun ^{[1
]}

Wang, Ruirui ^{[1
]}

Wang, Lei ^{[1
,2
,3
,4
]}

Liu, Qing ^{[1
]}

Han, Lan ^{[1
,2
]}

Duan, Xianchun ^{[1
]}

Zhang, Yanchun ^{[1
]}

Shen, Aizong ^{[5
]}

Peng, Daiyin ^{[1
,2
,4
,6
]}

Chen, Weidong ^{[1
,2
,4
,6
,7
]}

Ji, Zhaojie ^{[1
]}

机构：

[1] Anhui Univ Chinese Med, Coll Pharm, Hefei 230012, Peoples R China

[2] MOE, Anhui Joint Collaborat Innovat Ctr Qual Improvemen, Hefei, Peoples R China

[3] Anhui Acad Chinese Med, Inst Pharmaceut, Hefei, Peoples R China

[4] Anhui Prov Key Lab Chinese Med Formula, Hefei, Peoples R China

[5] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Pharm, Div Life Sci & Med, Hefei, Peoples R China

[6] Inst Tradit Chinese Med Resources Protect & Dev, Hefei, Peoples R China

[7] Anhui Prov Key Lab Tradit Chinese Med Decoct Piece, Hefei, Peoples R China

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 2023年 / 939卷

基金：

中国国家自然科学基金;

关键词：

Exosomes; Ischemic stroke; Biomarkers; Therapeutic measures; CELL-DERIVED EXOSOMES; NEURAL STEM-CELLS; EXTRACELLULAR VESICLES; FUNCTIONAL RECOVERY; CIRCULATING MICRORNAS; REPERFUSION INJURY; DELIVERY-SYSTEMS; MOUSE-BRAIN; PROTECT; DISEASE;

D O I：

10.1016/j.ejphar.2022.175477

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Ischemic stroke (IS) is the leading cause of long-term disability in the world and characterized by high morbidity, recurrence, complications, and mortality. Due to the lack of early diagnostic indicators, limited therapeutic measures and inadequate prognostic indicators, the diagnosis and treatment of IS remains a particular challenge at present. It has recently been reported that exosomes (EXOs) play a significant role in the pathogenesis and treatment of IS. The purpose of this paper is to probe the role of EXOs in diagnostic biomarkers and therapeutic measures for IS and to provide innovative ideas for improving the prognosis of IS.

引用

页数：12

共 50 条

[21] Serum biomarkers of ischemic stroke
Mahanova, A.
Topuzova, M.
Chaykovskaya, A.
Ternovykh, I.
Kovzelev, P.
Limarenko, V.
Korotkova, D.
Kipkeeva, A.
Zatej, A.
Vavilova, T.
Vasilieva, E.
Pospelova, M.
Simakov, K.
Sergeeva, T.
Alekseeva, T.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 876 - 876
[22] Blood Biomarkers of Ischemic Stroke
Glen C. Jickling
Frank R. Sharp
Neurotherapeutics, 2011, 8
[23] Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke
Jin, Meiqi
Zhang, Shuxia
Wang, Mengchen
Li, Qiaoyu
Ren, Jiahui
Luo, Yun
Sun, Xiaobo
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
[24] Native and Bioengineered Exosomes for Ischemic Stroke Therapy
Khan, Haroon
Pan, Jia-Ji
Li, Yongfang
Zhang, Zhijun
Yang, Guo-Yuan
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[25] Potential Role of Exosomes in Ischemic Stroke Treatment
Jiang, Lingling
Chen, Weiqi
Ye, Jinyi
Wang, Yilong
BIOMOLECULES, 2022, 12 (01)
[26] The Exosomes: Staring Biomarkers and Novel Therapeutic Strategies
Koosha, Farzad
Alimohammadi, Niloufar
Rafeian-Kopaei, Mahmoud
CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (35) : 3714 - 3721
[27] Significance of VEGF in Ischemic Stroke - Research for Biomarkers in Ischemic Stroke (REBIOS)
Matsuo, Ryu
Ago, Tetsuro
Kamouchi, Masahiro
Hata, Jun
Isomura, Tetsu
Watabe, Wakako
Awano, Hideto
Suzuki, Kazuo
Fukuda, Kenji
Okada, Yasushi
Kiyohara, Yutaka
Kitazono, Takanari
STROKE, 2011, 42 (03) : E203 - E203
[28] Exosomal microRNAs as Potential Biomarkers and Therapeutic Agents for Acute Ischemic Stroke: New Expectations
Xu, Yingzhi
Hu, Yue
Xu, Shixin
Liu, Fengzhi
Gao, Ying
FRONTIERS IN NEUROLOGY, 2022, 12
[29] Non-Coding RNA in Acute Ischemic Stroke: Mechanisms, Biomarkers and Therapeutic Targets
Wang, Sheng-Wen
Liu, Zhong
Shi, Zhong-Song
CELL TRANSPLANTATION, 2018, 27 (12) : 1763 - 1777
[30] Therapeutic management of ischemic stroke
Priya Bindal
Vishal Kumar
Lakshay Kapil
Charan Singh
Arti Singh
Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 2651 - 2679

← 1 2 3 4 5 →